Systemic inflammation induces various adaptive responses including tachycardia. Although inflammation-associated tachycardia has been thought to result from increased sympathetic discharge caused by inflammatory signals of the immune system 1 , definitive proof has been lacking. Prostanoids, including prostaglandin (PG) D 2 , PGE 2 , PGF 2α , PGI 2 and thromboxane (TX) A 2 , exert their actions through specific receptors: DP, EP (EP 1 , EP 2 , EP 3 , EP 4 ), FP, IP and TP, respectively 2 . Here we have examined the roles of prostanoids in inflammatory tachycardia using mice that lack each of these receptors individually. The TXA 2 analog I-BOP and PGF 2α each increased the beating rate of the isolated atrium of wild-type mice in vitro through interaction with TP and FP receptors, respectively. The cytokine-induced increase in beating rate was markedly inhibited in atria from mice lacking either TP or FP receptors. The tachycardia induced in wild-type mice by injection of lipopolysaccharide (LPS) was greatly attenuated in TP-deficient or FP-deficient mice and was completely absent in mice lacking both TP and FP. The β-blocker propranolol did not block the LPS-induced increase in heart rate in wildtype animals. Our results show that inflammatory tachycardia is caused by a direct action on the heart of TXA 2 and PGF 2α formed under systemic inflammatory conditions.
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We isolated the right atrium from wild-type mice or mice deficient in each type of prostanoid receptor, and examined chronotropic effects of a series of prostanoids. Adrenergic and muscarinic antagonists as well as indomethacin were added to the incubation medium to inhibit effects of the autonomic nervous system or of endogenous prostanoids, respectively. All the prostanoids tested increased the beating rate of the wild-type atrium in a concentration-dependent manner from the basal rate of 260 beats/min to a plateau level of >400 beats/min; these effects occurred within 3 min of the addition and continued for more than 1 h, although the potencies were different among these compounds (Fig. 1a-e and Supplementary Fig. 1 online) .
For example, the response to PGF 2α was first detected at 1 nM and reached a plateau at 30 nM. This positive chronotropic effect of PGF 2α was not observed in the atrium of mice lacking FP (Ptgfr -/-mice), indicating that it was mediated by FP (Fig. 1a) . In contrast, PGD 2 , PGE 2 and PGI 2 each showed a positive chronotropic effect in both wild-type atria and atria derived from mice lacking their respective receptors; these effects, however, were not apparent with FP-deficient atria, suggesting that they were mediated not by their cognate receptors but by FP (Fig. 1b-e) .
The stable TP agonist I-BOP induced a biphasic increase in the beating rate of the wild-type atrium; the first phase of this effect was apparent at 3 pM and reached a plateau of 370 beats/min at 100 pM, and the second phase was apparent at 30 nM and reached a level of 400 beats/ min at 1 µM (Fig. 1f) . The first phase of the response was not observed in atria of mice lacking TP (Tbxa2r -/-mice), which showed more clearly the second phase of the response at submicromolar I-BOP concentrations. In contrast, FP-deficient atria showed only the first phase of the response to I-BOP. These results thus indicated that TP and FP mediate the first and second phases of the biphasic chronotropic effect of I-BOP, respectively. A small but reproducible difference was apparent between the beating rates attained by stimulation of FP or TP alone, whereas the maximal beating rate of the wild-type atrium induced by stimulation of both FP and TP was similar to that induced by stimulation of FP alone. These observations suggest that TP probably increases the beating rate by the same signaling mechanism as does FP, but with a lower efficacy. Both PGF 2α and TXA 2 thus each act directly on the atrium to induce an increase in beating rate through interaction with their cognate receptors. Furthermore, PGD 2 , PGE 2 and PGI 2 each exert positive chronotropic actions by cross-reacting with FP at relatively high concentrations, which might not be achieved under physiological conditions.
We next examined whether such direct stimulation of the heart by prostanoids contributes to the chronotropic actions of the autonomic nervous system. Atria from wild-type mice or from mice deficient in FP or TP were incubated with either epinephrine or acetylcholine in the absence of indomethacin and other blockers. The positive or nega-tive chronotropic effects elicited by epinephrine and acetylcholine, respectively, did not differ substantially among the atria from wildtype mice and from the various types of receptor-deficient animals ( Supplementary Fig. 2 online) , suggesting that these actions of epinephrine and acetylcholine are independent of prostanoids. Conversely, both propranolol and atropine did not significantly affect the PGF 2α -induced increase in beating rate (data not shown), suggesting that FP signaling was independent of adrenergic or muscarinic signaling.
To determine whether prostanoids act on pacemaker tissue, we divided the right atrium into three portions: the nodal area, transitional area and auricle (Fig. 2a) . The nodal area contains the sinoatrial node, and the transitional area contains transitional cells 3 , which show automaticity after they are freed from control by the nodal pacemaker. The auricle does not contain any pacemaker tissue. The isolated nodal area showed a beating rate (281 ± 7 beats/min) similar to that of the whole atrium, confirming that it contained the sinoatrial node (Fig. 2b) . Both PGF 2α (10 nM) and I-BOP (1 nM) showed potent positive chronotropic effects in the nodal area, as did epinephrine. The transitional area acquired automaticity on isolation but showed a beating rate (251 ± 16 beats/min) lower than that of the nodal area (Fig. 2c) . I-BOP significantly increased the beating rate of this tissue, as did epinephrine, but PGF 2α had no such effect, indicating that the expression of FP and TP might differ between the nodal and transitional areas. The isolated auricle did not show automaticity, and no rhythm was induced by either PGF 2α or I-BOP (data not shown). These results thus indicate that PGF 2α and I-BOP each exert their chronotropic effects by acting on the confined regions of the atrium that contain the pacemaker cells. In addition, we found that both I-BOP and PGF 2α significantly (P < 0.05) increased diastolic depolarization rate, shortened action potential duration, and thus increased beating rate in a concentration-dependent manner in an electrophysiological experiment using isolated guinea-pig nodal cells (K.O., K.Y., T.I. & F.U., unpublished observation), suggesting direct actions of these prostanoids on the pacemaker cells. It remains to be determined whether FP and TP are expressed in the pacemaker cells or which type(s) of ion channel mediates the actions of these prostanoids.
We next determined whether endogenously produced prostanoids also elicit positive chronotropic effects in the isolated right atrium. We first compared beating rates among atria from wild-type, FP-deficient and TP-deficient mice under basal conditions in the absence of indomethacin and found no significant difference (data not shown), suggesting that the basal production of both PGF 2α and TXA 2 were not sufficient to affect this parameter. We therefore administered a mixture of interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ to the atrial preparation to stimulate the production of endogenous prostanoids. These agents are typical inflammatory cytokines that are released in large amounts into the circulation under systemic inflammatory conditions and stimulate prostanoid synthesis in various organs 4 . Indeed, the cytokine mixture significantly (P < 0.05) increased syntheses of both TXA 2 and PGF 2α in the wild-type atrium (Fig. 3a) and induced a biphasic increase in the beating rate, with the first and second peaks apparent 20 and 80 min after cytokine addition (Fig. 3b) . IL-1β alone could also induce a similar degree of increase in the beating rate to that induced by the cytokine mixture (data not shown).
The first peak was not observed with the TPdeficient atrium, whereas the second-phase increase was not seen in the FP-deficient atrium (Fig. 3c) , indicating that the first and second phases were mediated by TXA 2 and PGF 2α , respectively. In addition, both phases were abolished by pretreatment of the wildtype atrium with indomethacin, which inhibits both cyclooxygenase (COX)-1 and COX-2, rate-limiting enzymes of prostanoid synthesis. These results indicate that inflammatory cytokines stimulate the production of TXA 2 and PGF 2α in the right atrium, and that these prostanoids mediate distinct phases of the positive chronotropic response to the cytokines. It is noteworthy, however, that platelets might have a role as a source of TXA 2 under a systemic inflammatory condition, in which platelets would be activated and release TXA 2 in large amounts. Finally, we investigated whether the PGF 2α -FP system and the TXA 2 -TP system mediate tachycardia in vivo under systemic inflammatory conditions. Mice injected with LPS, a major constituent of the cell wall of Gram-negative bacteria, are a well established model of acute inflammation 4 , and we therefore administered this polymer to mice to stimulate the production of inflammatory cytokines. Administration of LPS to wild-type mice induced a biphasic increase in heart rate characterized by a transient peak (early phase) at 20 min followed by a sustained increase (late phase) that persisted for at least 100 min after LPS injection (Fig. 4a) . In TP-deficient mice, the early phase, although not completely absent, was greatly diminished, whereas the late phase was similar to that apparent in wild-type mice (Fig. 4b) , suggesting that the TXA 2 -TP system mediates predominantly the early phase of LPS-induced tachycardia. In FP-deficient mice, LPS induced only the early phase of the increase in heart rate, indicating that the late phase of LPS-induced tachycardia is mediated by the PGF 2α -FP system.
To verify further the contributions of TXA 2 and PGF 2α , we generated mice deficient in both FP and TP (Ptgfr -/-Tbxa2r -/-mice) and examined the effect of LPS on their heart rate. The heart rate of LPStreated Ptgfr -/-Tbxa2r -/-mice did not differ substantially from that of vehicle-treated wild-type mice (Fig. 4b) , indicating that TXA 2 and PGF 2α indeed mediate all components of LPS-induced tachycardia in vivo. Moreover, pretreatment of wild-type mice with indomethacin also prevented the effect of LPS on heart rate ( Fig. 4c) , confirming the role of prostanoids in LPS-induced tachycardia. We further examined the relative contribution of COX-1 and COX-2 to LPS-induced tachycardia using their selective inhibitors, SC560 and SC58125, respectively. SC560 suppressed the early phase, and SC58125 suppressed the late phase of LPS-induced tachycardia, indicating that COX-1 and COX-2 were involved preferentially in the early and late phases, respectively (Fig. 4c) . In contrast, pretreatment of wild-type mice with propranolol reduced the basal heart rate by ~100 beats/min but did not block the effect of LPS (Fig. 4d) . In addition, propranolol reduced also the basal heart rate without changing the profiles of heart rate in both FP-deficient mice and TP-deficient mice (data not shown). Furthermore, LPS had no significant effect on blood pressure during the experimental period ( Supplementary Fig. 3 online) , excluding the possibility that LPS-induced tachycardia was the result of a hemodynamic change. These results indicate that the LPS-induced increase in heart rate is not mediated by enhancement of the activity of the sympathetic nervous system but rather results from the direct positive chronotropic actions of TXA 2 and PGF 2α on the heart.
The demand for oxygen and nutrients to combat invading microorganisms increases greatly in peripheral tissues under systemic inflammatory conditions 5 . This demand is met in part by an adapa b c tive hyperdynamic state characterized by tachycardia, tachypnea and fever, as is apparent during the early phase of septic shock 6 . The immune system and central nervous system are thought to mediate the development of this hyperdynamic state in a coordinated manner through the actions of various cytokines and autonomic nerves 1, 7, 8 . Nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and indomethacin, are frequently used to alleviate the symptoms that accompany such a hyperdynamic state; these drugs reduce tachycardia as well as fever. The effect of NSAIDs on heart rate has been thought to result from a reduction in sympathetic tone caused by their antipyretic action. We have now shown that the suppressive effect of the β-blocker propranolol on heart rate in LPS-treated mice was achieved by slowing the basal heart rate rather than by preventing the induction of tachycardia. In addition, a pattern of tachycardia in response to LPS in mice lacking EP 3 , which showed a defective febrile response to LPS 9 , was nevertheless similar to that in wild-type mice (data not shown), suggesting that febrile response and inflammatory tachycardia are independent events mediated by the different prostanoids. Our results thus indicate that NSAIDs act directly at a site in the atrium to suppress tachycardia under systemic inflammatory conditions. It is an important issue whether the present mechanism works also in humans. There have been few reports suggesting a role of prostanoids in the regulation of heart rate, indicating that few investigators suspect a direct relationship between prostanoids and heart rate under systemic inflammatory conditions. There have been, however, several pioneering works reporting a potent suppressive effect of NSAIDs on inflammatory tachycardia. One study examined the effect of ibuprofen, a popular NSAID, on heart rate in healthy volunteers after administration of LPS, and found its potent suppressive effect on tachycardia 10 . In addition, another study examined the effect of ibuprofen on heart rate in 455 individuals with septicemia, and found its potent and prompt suppressive action on tachycardia 11 . These reports suggest that the prostanoids have a role in inflammatory tachycardia in humans, but their role remains to be characterized further.
The contribution of prostanoids to the establishment of the hyperdynamic state has been largely unknown. We recently showed that PGE 2 functions as a crucial mediator of the febrile response by acting in the preoptic area through EP 3 (ref. 9) , and that it also participates in the activation of the hypothalamic-pituitary-adrenal axis during the acute-phase response through EP 1 and EP 3 (ref. 12) . These previous findings, together with our present observations that PGF 2α and TXA 2 mediate inflammatory tachycardia, thus show that prostanoids have central roles in the acute-phase response as part of the defense of the body against microbial invasion.
METHODS
Mice. Generation and maintenance of mice lacking each of the prostanoid receptors have been described 9, [13] [14] [15] [16] [17] [18] . These animals, with the exception of Ptger4 -/-mice (mice lacking EP 4 ), and wild-type control mice share a genetic background similar to that of C57BL/6. Ptger4 -/-mice have the mixed genetic background of 129/svOla and C57BL/6; F 2 wild-type mice, with a genetic background similar to that of Ptger4 -/-mice, were used as a control for experiments with these latter animals (Fig. 1d) . Ptgfr -/-Tbxa2r -/-mice were generated by crossing Ptgfr -/-and Tbxa2r -/-mice. All experiments, which were approved by the Asahikawa Medical College Committee on Animal Research, were performed with 8-12-week-old female mice.
Isolation of atria and measurement of beating rate. We excised the heart from mice anesthetized by intraperitoneal injection of ketamine (100 mg/kg) and xylazine (5 mg/kg), and separated the right atrium in Krebs-Henseleit solution.
The atrium was then mounted in an organ bath filled with 10 ml of the solution aerated with 95% O 2 and 5% CO 2 at 36 ± 0.5 °C. We measured the beating rate of the atrium by monitoring tension with a force-displacement transducer connected to a polygraph recorder. After a stabilization period of 1 h under 0.5 g of tension, each prostanoid, epinephrine or acetylcholine was added cumulatively to the bath. When examining the effects of prostanoids, we minimized neuronal effects by adding propranolol (1 µM), phenoxybenzamine (1 µM) and atropine (1 µM) to the bathing solution and we also inhibited the endogenous production of prostanoids by adding indomethacin (5 µM). When examining the effect of inflammatory cytokines, we stimulated the atrium with a mixture of IL-1β (20 ng/ml), TNF-α (20 ng/ml), and IFN-γ (10 ng/ml) in the presence of propranolol, phenoxybenzamine and atropine (each at 1 µM). We also measured the concentrations of TXB 2 , a stable metabolite of TXA 2 , and PGF 2α in the bathing medium at 20 and 80 min after the cytokine addition using EIA kits (Cayman Chemical).
Electrocardiograph recordings.
To examine the site of action of prostanoids, we divided the right atrium of wild-type mice into three portions in Krebs-Henseleit solution. The action potentials from each portion were monitored with a needle electrode connected to an electrocardiograph. The tissue was stimulated with PGF 2α (10 nM) or I-BOP ([1s (1α, 2β (5Z), 3α (1E, 3S*), 4α)]-7-[3-(3-hydroxy-4-4′-iodophenoxy)-1-butenyl)-7-oxabicyclo-[2.2.1] heptan-2-yl]-5-heptanoic acid 18 ; 1 nM) in the presence of propranolol, phenoxybenzamine, atropine and indomethacin. The effect of epinephrine (1 µM) was examined in the absence of these compounds.
Heart rate and blood pressure measurements. We measured heart rate and blood pressure of conscious mice by the tail-cuff method with a BP-98A instrument (Softron) as described 19 . In this study, we referred heart rate to represent cycle length of heart contraction. After an acclimatization period of 20 min, the basal heart rate and blood pressure were measured and then LPS (026:B6, Sigma) was injected intraperitoneally at a dose of 10 mg/kg. When examining the effects of an adrenergic antagonist or COX inhibitors, propranolol (1 mg/kg) and indomethacin (10 mg/kg) were injected intraperitoneally 30 min before LPS injection, and SC560 (10 mg/kg, Cayman Chemical) or SC58125 (10 mg/kg) were injected intraperitoneally 120 min before LPS injection. Although indomethacin inhibits both COX-1 and COX-2, SC560 and SC58125 are selective inhibitors for COX-1 and COX-2, respectively 20, 21 .
Statistical analysis. Data are presented as means ± s.e.m. and the significance of differences was evaluated by Student t-test. A value of P < 0.05 was considered statistically significant. Analysis and graphing of the data were performed with Prism III software (GraphPad Software).
